RNAC Selecta Biosciences Inc

$RNAC Might be time to accumulate: - Phase 3 readout in 3-6 months - Strong phase 2b results, peer reviewed in Nature Medicine - Analyst average target is 4.4x current value - Quiet in here and on Reddit, muted volume, I’d say retail hasn’t spotted the setup yet Could be a fun few months.

$RNAC if phase 3 meets the primary end point with similar efficient of phase 2, there is a potential for ABIVAX 2.0. Recent data is also nice, even though n=5. That means there might be a constant revenue as well with once in every 1-2 years of dosing. Only problem is dosing takes 6 weeks, it’s too long.